Defining cellular complexity in human autosomal dominant polycystic kidney disease by multimodal single cell analysis.
Yoshiharu MutoEryn E DixonYasuhiro YoshimuraHaojia WuKohei OmachiNicolas LedruParker C WilsonAndrew J KingN Eric OlsonMarvin G GunawanJay J KuoJennifer H CoxJeffery H MinerStephen L SeligerOwen M WoodwardPaul A WellingTerry J WatnickBenjamin D HumphreysPublished in: Nature communications (2022)
Autosomal dominant polycystic kidney disease (ADPKD) is the leading genetic cause of end stage renal disease characterized by progressive expansion of kidney cysts. To better understand the cell types and states driving ADPKD progression, we analyze eight ADPKD and five healthy human kidney samples, generating single cell multiomic atlas consisting of ~100,000 single nucleus transcriptomes and ~50,000 single nucleus epigenomes. Activation of proinflammatory, profibrotic signaling pathways are driven by proximal tubular cells with a failed repair transcriptomic signature, proinflammatory fibroblasts and collecting duct cells. We identify GPRC5A as a marker for cyst-lining collecting duct cells that exhibits increased transcription factor binding motif availability for NF-κB, TEAD, CREB and retinoic acid receptors. We identify and validate a distal enhancer regulating GPRC5A expression containing these motifs. This single cell multiomic analysis of human ADPKD reveals previously unrecognized cellular heterogeneity and provides a foundation to develop better diagnostic and therapeutic approaches.
Keyphrases
- single cell
- polycystic kidney disease
- rna seq
- induced apoptosis
- endothelial cells
- transcription factor
- high throughput
- cell cycle arrest
- signaling pathway
- end stage renal disease
- oxidative stress
- peritoneal dialysis
- induced pluripotent stem cells
- chronic kidney disease
- pi k akt
- gene expression
- binding protein
- pluripotent stem cells
- endoplasmic reticulum stress
- poor prognosis
- epithelial mesenchymal transition
- chronic pain
- cell death
- cell proliferation